logo
Opinions and lifestyle survey launched in Jersey

Opinions and lifestyle survey launched in Jersey

BBC News30-05-2025
An annual survey set up to study Jersey islanders' experiences and views on certain topics has been launched.The government said Statistics Jersey's 2025 Opinions and Lifestyle Survey would be sent to 4,200 randomly selected households with the aim of helping to plan and deliver public services in the future.The person in the household who has their birthday next and is aged over 16 would be asked to complete the survey online to give a good range of ages for those responding, the government said.It added paper copies of the survey were also available and anyone selected to complete it had until 20 June to fill out the form.
"The results of the survey will be published later this year," the government said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

DAILY MAIL COMMENT: Keir Starmer must fight for UK drug firms
DAILY MAIL COMMENT: Keir Starmer must fight for UK drug firms

Daily Mail​

time17 minutes ago

  • Daily Mail​

DAILY MAIL COMMENT: Keir Starmer must fight for UK drug firms

The life sciences industry is among the brightest jewels in the British economy, generating £100billion a year and employing more than 300,000 people. At its heart is the development and manufacture of pharmaceuticals, notably by AstraZeneca, which spends vast sums on research and is worth £167billion. So, if this hugely successful company were to relocate to the US, it would be a disaster both for the London Stock Exchange and the wider economy. Worryingly, this is not out of the question. AstraZeneca already sells 40 per cent of its drugs to America and, following President Donald Trump 's tariff threat, is ramping up research and production there. While there are no immediate plans to desert the UK, chief executive Pascal Soriot is said to be 'flirting' with the idea. Mr Trump's latest demand that foreign drug companies cut prices to US customers or face penalties may be an added incentive. The Left has always been highly critical of 'Big Pharma', accusing it of profiteering on the backs of NHS patients. Under Jeremy Corbyn, Labour planned to create a state-owned drug manufacturer with the power to override the patents which enable firms to make profits from their research. Only last year, Sir Keir Starmer refused to help fund a new vaccine plant in Liverpool – while pouring public money into our ailing steel industry. This Government must understand that failing to nurture AstraZeneca, GSK and others would be a catastrophic mistake. And Sir Keir should realise that while they say they want to remain in the UK, they may yet change their mind. Car lenders off hook Banks and credit providers will have heaved a huge sigh of relief yesterday after the Supreme Court ruled they will not have to pay compensation to millions of motorists who bought cars on finance without being told the dealers were receiving commission on the loan. The Treasury was also delighted with the result. Had it gone the other way, damages could have been comparable to the PPI scandal, which destabilised the financial industry for more than a decade. The court decided that dealers did not have a duty to act solely for buyers and that commissions were not a form of bribery in the legal sense, as had been alleged. However, it was not a total exoneration. Court President Lord Reed also ruled that excessive commission payments were unfair and ordered one buyer who had been charged 25 per cent of the value of the car to be repaid with interest. This opens the way to further claims. Many brokers and dealers were paid behind-the-scenes commission by lenders to sign buyers up to car finance deals, a practice deemed 'unlawful' by the Court of Appeal in October last year - a decision that was successfully appealed by lenders at the Supreme Court The dealers and lenders have escaped their worst fears, but they do not come out well. They have certainly been guilty of sharp practices even if not illegal ones. The Competition and Markets Authority must now force them to clean up their act. OAPs feel the cold In September, Rachel Reeves promised she would 'put more money in pensioners' pockets'. What she didn't say is that she would take even more out. Research shows pensioner households are an average of £800 worse off after a year of Labour thanks to higher bills – mainly owing to the Chancellor's £40billion Budget tax raid. With more taxes coming down the track to fill Labour's ever-widening financial black hole, the cost of living is set to soar further. For all Ms Reeves' promises, the elderly are in for a bitter winter.

My haunted Cotswolds house that proves hauntings are real. NADINE DORRIES thought she'd found her forever home. Then after family deaths and sinister encounters that terrified her children, she called a priest...
My haunted Cotswolds house that proves hauntings are real. NADINE DORRIES thought she'd found her forever home. Then after family deaths and sinister encounters that terrified her children, she called a priest...

Daily Mail​

time17 minutes ago

  • Daily Mail​

My haunted Cotswolds house that proves hauntings are real. NADINE DORRIES thought she'd found her forever home. Then after family deaths and sinister encounters that terrified her children, she called a priest...

Do you believe a house can be haunted or cursed? I didn't – until I lived in one. Last month, I read about the tragic death of Beverley Allen, the first wife of former F1 boss Christian Horner and mother of his teenage daughter, who passed away at 58 after a cancer battle.

Trump demands UK pharmaceutical giants to lower drug costs sparking fears NHS could pay the price if they refuse
Trump demands UK pharmaceutical giants to lower drug costs sparking fears NHS could pay the price if they refuse

Daily Mail​

timean hour ago

  • Daily Mail​

Trump demands UK pharmaceutical giants to lower drug costs sparking fears NHS could pay the price if they refuse

Donald Trump has demanded UK pharmaceutical giants lower prices for America and suggested charging others to make up the difference. He said if they didn't, the US would deploy 'every tool in our arsenal' to protect families from 'continued abusive drug prices', sparking fears the NHS will end up paying more. Mr Trump suggested he would use tariffs to push through higher prices if countries resisted. In May Mr Trump signed an executive order demanding drugmakers cut US medicine prices to match those abroad. Yesterday in a letter to 17 pharma companies he said he expected them to deliver on measures by September 29. He asked them to apply 'most favoured nation' pricing to Medicaid, the US health programme for people on low incomes. Mr Trump also asked drugmakers to offer new medicines at the same price in the US as in other developed countries. He said: 'Our citizens pay massively higher prices than other nations pay for the same exact pill... subsidizing socialism aboard [abroad].' British pharma companies AstraZeneca and GSK were among the recipients. Others included Eli Lilly, Johnson & Johnson, Pfizer and Sanofi. The UK Government said it would 'continue to work closely with the US to get the best deal for our pharma industry and deliver mutual benefits for both our countries'.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store